Abstract:OBJECTIVE:This experiment was designed to study the effect of small molecule tripeptide CMS024 on tumor growth and metastasis in a nude mice model of human hepatocellular carcinoma (HCC) metastasis. METHODS:Highly metastatic human HCC cell strain HCCLM6 was injected into subcutaneous region of nude mice. When the subcutaneous tumor reached 0.8 cm in diameter, the tumor was removed and cut into small pieces about 1 mm in diameter and implanted orthotopically into the liver of 20 BALB/c nude mice, which were randomized into treatment group and control group each with 10 mice. The treatment group received daily CMS024 intraperitoneal injection at the dose of 300 microg/kg beginning from the second postoperative day. The control group received intraperitoneal injection of equal amount of 0.85% sodium chloride solution. The mice were observed for signs of disease development. Thirty-five days later, the mice were sacrificed and abdominal and pulmonary metastases were recorded and peripheral blood hematological and biochemical parameters were determined. RESULTS:After 35 days of intervention, all the 10 mice in the treatment group were alive and well, but there were only 9 living mice in the control group. The mean tumor weights were 1.9 g +/- 0.5 g in the treatment group and 2.3 g +/- 0.8 g in the control group (P > 0.05). The abdominal wall metastases and intraperitoneal metastases were 100% for the control group and only 60% and 50%, respectively, for the treatment group (P < 0.05). Bloody ascites and gross intrahepatic metastatic nodules were found in 70% and 90% of nude mice, respectively, for the control group, and 20% and 40%, respectively, for the treatment group (P > 0.05). The median number of grades I, II, III and IV pulmonary metastases were 92, 24, 15 and 16, respectively, for the control group, and 24, 20, 10 and 8, respectively, for the treatment group. There were statistically significant differences in the number of grade I pulmonary metastases between the treatment group and the control group (24 vs 92, P < 0.05). No statistically significant differences in the body weight, peripheral blood hematological and biochemical parameters were observed between the two groups. No toxic effects were observed during the observation period. CONCLUSIONS:Small molecule tripeptide CMS024 demonstrated positive effects to retard tumor growth and inhibit loco-regional and long distance metastases in a nude mice model of human HCC metastasis, and no obvious toxic or side effects on the tumor bearing nude mice.

Isomalto Oligosaccharide Sulfate Inhibits Tumor Growth and Metastasis of Hepatocellular Carcinoma in Nude Mice

Effects of Isomalto Oligosaccharide Sulfate on HCCLM3 Xenograft Growth in Nude Mice

The Effects of IMOS on HCC Proliferation,Cell Cycle and Apoptosis

Effects of Carboxymethyl Chitosan Oligosaccharide on Regulating Immunologic Function and Inhibiting Tumor Growth.

Sialic Acid-Modified O-GlcNAc Transferase Inhibitor Liposome Presents Antitumor Effect in Hepatocellular Carcinoma

Metal-free Imidazolium Salts Inhibit the Growth of Hepatocellular Carcinoma in a Mouse Model

Multiple Targeted Self-Emulsifying Compound RGO Reveals Obvious Antitumor Potential&nbsp;in Hepatocellular Carcinoma

The Study of Inhibition Effect of Octreotide on the Growth of Hepatocellular Carcinoma Xenografts in Situ in Nude Mice

Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis

Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells

Sanshimao formula inhibits the hypoxia-induced pro-angiogenesis of hepatocellular carcinoma cells partly through regulating MKK6/p38 signaling pathway

Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models.

Effect of Oroxylum Indicum on Hepatocellular Carcinoma Via the P53 and VEGF Pathways Based on Microfluidic Chips

Targeting CD36-Mediated Lipid Metabolism by Selective Inhibitor-Augmented Antitumor Immune Responses in Oral Cancer

Preparation and Anti-Tumor Metastasis of Carboxymethyl Chitosan.

Study on the Inhibitory Effect of Small Tripeptide CMS024 on Tumor Growth and Metastasis in Nude Mice Model of Human Hepatocellular Carcinoma Metastasis

Sulfated Alginate Oligosaccharide Exerts Antitumor Activity and Autophagy Induction by Inactivating MEK1/ERK/mTOR Signaling in a KSR1-dependent Manner in Osteosarcoma

Solamargine Inhibits the Growth of Hepatocellular Carcinoma and Enhances the Anticancer Effect of Sorafenib by Regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 Pathway

Antitumor Activity of a Sulfated Polysaccharide from Enteromorpha Intestinalis Targeted Against Hepatoma Through Mitochondrial Pathway

(2E)-1-(2,4,6-Trimethoxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one, a Chalcone Derivative, Promotes Apoptosis by Suppressing RAS-ERK and AKT/FOXO3a Pathways in Hepatocellular Carcinoma Cells

ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma Via Downregulation of PI3K/AKT/mTOR Pathway in Vivo and in Vitro